Playing Devil’s Advocate: Is Corporate Efficiency a Necessary Evil?

So far, we have painted a fairly bleak picture of the corporate healthcare machine. We’ve looked at the impossible 93% productivity requirements, the moral injury of the 4-minute non-billable window, the unpaid labor epidemic, and the invisible real estate landlords siphoning off profits.

But it wouldn’t be fair if we didn’t at least entertain the other side of these arguments. And to do that, we have to ask an uncomfortable question: Is it possible that these financial incentives and corporate efficiency are actually helpful or necessary in healthcare?

Well… Is it?

Proponents of corporate healthcare argue that private equity firms, strict metrics, and profit incentives aren't a part of a greedy system—they are the exact mechanisms that save failing facilities and fund the future of medicine.

Let's look at the controversial role of Private Equity (or PE) firms in hospitals, for example. The popular narrative is that PE firms buy struggling hospitals, strip them for parts, fire everyone, and leave the community stranded. We’ve all heard this sad story. But is this entirely true? 

A large, comprehensive study of PE hospital acquisitions tells a surprisingly different story. First, PE-acquired hospitals do not have higher closure rates than their peers. When you hear about aggressive cost-cutting that leaves patients suffering and clinicians starving for time, you naturally assume the facility is in a financial crisis, barely scraping by just to keep the doors open. But that is actually a myth.

In reality, these corporate owners easily sustain their own survival rates. Instead of scraping by, their profitability skyrockets, as they magically squeeze an extra $5 of pure profit out of every $100 of assets they hold. This, of course, isn’t always a good thing, as we already discussed. Profit doesn’t necessarily mean better care; it can often mean the opposite.

But you might be surprised to hear how some of these firms achieve their profitability. Yes, they downsize staff, but they aren’t primarily focused on clinicians, as you might think. Instead, walk through the administrative wing of a recently acquired hospital, and you’ll see that 1 out of every 5 desks has been permanently emptied. The clinical staff remains the same, but the people answering the phones, fighting with insurance, and keeping the hospital functioning are simply gone.

I’m not saying this is necessarily a good thing, but being a clinician, it’s certainly nice to see that we aren’t the first to go.

And how do some of these changes impact patient care? Gao & colleagues examined patient outcomes and found that 30-day mortality and readmission rates for severe conditions like heart attacks, heart failure, and pneumonia did not worsen under PE ownership.

From this angle, corporate intervention and trimming the fat to improve operational efficiency might just be the life rafts keeping struggling hospitals from going under. 

The Multi-Billion Dollar Price Tag of Innovation

Let's not forget where a gigantic chunk of industry profits is supposed to go: Innovation. In a capitalistic economy, the drive to create better, life-saving products requires capital. A lot… of capital. For example, developing, researching, and launching a single new pharmaceutical drug costs an estimated $1.7 billion. Billion. With a B. For a single drug.

To understand that scale, imagine a research lab being handed a daily budget of $50,000. They would have to spend that $50,000 every single day, seven days a week, for 93 straight years just to equal the cost of bringing one single drug to market.

And where does the United States fall with all of this spending? To put this in perspective, imagine all global spending on pharmaceuticals as a single $10 bill. Out of every $10 spent on drugs anywhere in the world, the US alone pays over $4 of it.

The truth is the more a firm spends on research and development, the higher its market value climbs, perpetuating spending to the absolute limit. And without those massive U.S. dollars driving the profit incentives to take financial risks, research and development could grind to a halt, starving patients of the next generation of life-saving medical advancements.

Trust me, I don’t love having private equity and financial incentives wrapped up in patient care either. But if it means better care and more lives saved? It might be worth considering parts of the system that are already in place. Don’t throw the baby out with the bath water, right?

Medicare-For-All

So, if corporate profits are a necessary driver for innovation, why don't we just have the government foot the bill and guarantee coverage for everyone? Many advocate for a "Medicare for All" single-payer system to eliminate health disparities. To be clear, I’m not for or against Medicare for All. Would there be benefits? Absolutely? Would there be issues? Absolutely.

Specifically, physicians warn that simply writing a blank check wouldn't magically fix patient outcomes. First, how much would that blank check be? Some argue around $32 trillion.

Let's look at what that $32 trillion check actually means. It is the equivalent of billing every single man, woman, and child in America $100,000 over the next decade. Even after handing over that massive sum, the system would still be broken. Why?

Because health is dictated by socioeconomic factors, not just an insurance card. 

To prove this, look at the Whitehall study, a landmark report that tracked over 17,000 British civil servants. Every single person in the study had universal healthcare through the National Health Service. Yet, researchers still found a direct, undeniable correlation between a person’s civil service job rank and their life expectancy.

To illustrate exactly what this looks like in the real world, consider this scenario:

Imagine two patients who both suffer the exact same injury. Let’s say it's a tibia fracture. They both receive the exact same operation and are referred to your clinic for rehabilitation. To make it a fair comparison, let's assume they both have complete medical coverage, so the physical and occupational therapy doesn't cost either of them a single dime. Patient A is a high-income earner, and Patient B is a low-income worker. Who heals better and regains their independence faster?

The reality is that the wealthier patient will likely end up with a much better functional result, and it has nothing to do with their insurance card.

It is because Patient A has what researchers call social capital. They generally have better underlying health, fewer comorbidities, and are less likely to smoke (statistically speaking), which directly affects how well their bone heals. Furthermore, they are more likely to have a robust network of friends and family who can easily drive them to their physical therapy appointments.

Most importantly, when you educate them on energy conservation, work simplification, or the need for specific adaptive equipment at home, the wealthier patient actually has the financial and social resources to implement those changes. They can more easily negotiate accommodations at work so they can follow your instructions to stay off the leg.

The lower-income patient simply doesn't have those luxuries; they might frequently cancel therapy sessions due to transportation issues, or be forced back onto their feet too soon just to keep their job. 

This doesn’t just apply to a broken leg. It applies to any kind of health condition. 

Orthopedic surgeons point to another fascinating natural experiment here in the U.S.: Workers' Compensation patients. These patients have coverage that is actually better than Medicare for All. They have zero co-pays, zero deductibles, paid time off, free medical equipment, and even free transportation to therapy.

Yet, their clinical outcomes are consistently worse. And not just a little worse: Twice as bad. Twice the risk of a negative outcome' sounds clinical on a spreadsheet, but on the clinic floor, it means doubling the number of patients who suffer a preventable fall, catch a dangerous pneumonia, or face a life-threatening complication. 

So, even when all financial barriers are removed, patients still struggle if their underlying socioeconomic factors aren't addressed, such as their diet, workplace accommodations, and community support.

Finding the Middle Ground: What Actually Needs to Change?

So, here we are, caught between two conflicting realities. On the one hand, we can’t simply have a disorganized, unaccountable spending spree. We need fiscal discipline, operational efficiency, and profit-driven R&D to keep hospitals open and invent tomorrow's cures. On the other side, we have frontline clinicians suffering from immense stress and pressure, forced to work off the clock, and even a pipeline of future students being choked off because facilities are too distracted with daily productivity metrics to allocate time for education and training. 

Something has to give.

Based on the data across the board, here are the logical, evidence-based changes we must make to reconcile corporate efficiency with clinical ethics:

1. Trim the Right Fat: Private equity data proves that hospitals can improve profitability by targeting administrative waste (an 18-22% reduction) without permanently losing care providers. We have to stop squeezing 4-minute windows from bedside clinicians and instead target the bloated administrative costs and exorbitant corporate-landlord rents that are draining facility budgets.

2. Redefine Productivity: The Medicare and Workers' Comp data clearly prove that a patient's recovery depends heavily on not just their financial capital, but also their social capital. This is their ability to manage lifestyle changes, coordinate transportation, or navigate community support. But how can a clinician help their patients work through these socioeconomic barriers if their employer only gives them four non-billable minutes an hour? We must redefine productivity to include the non-billable time required to treat the whole patient. Our recommendations and our plans of care are meaningless if the patient can’t figure out how to get to their appointments.

3. Give Clinicians a Seat at the Table: The data is crystal clear: when clinicians are allowed to participate in setting their own productivity goals, they are much less likely to see unethical behaviors in the workplace. Furthermore, facilities that place a strong organizational emphasis on ethics and evidence-based practice experience a significant reduction in fraudulent billing and skipped care. Administrators must stop managing from spreadsheets and start collaborating with the professionals on the floor. And as clinicians, we have to speak up, be heard, and help make this change possible (More on this later).

4. Shift from Volume to Value: We must stop demonstrating our worth by answering the only question that’s ever asked of us: "How many units did we bill today?" Without that question, there is a void, and in that void there is an opportunity to fill it with meaning and value. 

So, what should we be measuring? 

We need to start measuring the quality of the outcomes we are achieving for our patients. And when we succeed, we shout it from the top of a mountain so everyone can hear not only that we did it, but also how we did it… so it can be replicated.

Only when we balance the need for corporate financial sustainability with the ethical and human needs of the clinician and the patient will we finally build a healthcare system that does what it’s supposed to do: heal the patient.

Next week, we’re going to talk about some specific outcomes we should measure and highlight in our facilities to move the needle forward in this battle against unrealistic productivity standards. I’ll see you there!